Authors
Latest:
The Pharmacist’s Role in Maximizing HIV Antiretroviral TherapyThrough ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.
Latest:
Trending News Today: Study Links Prenatal Nicotine Exposure to ADHD in OffspringTop news of the day from across the health care landscape.
Latest:
Medical Benefit Specialty Drug Management–A Call to ActionSpecialty drug trend management typically focuses on drug formulations administered via a payer or plan sponsor pharmacy benefit, which overlooks drug spending occurring under a payer or plan sponsor medical benefit.
Latest:
Opioid Overdose and Naloxone Delivery Devices in the Community SettingAlthough naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Latest:
Current and Emerging Therapeutics in Cystic Fibrosis: Ensuring Continuity of Care within the New Treatment ParadigmThis Continuing Education activity is supported by an educational grant from Vertex Pharmaceuticals, Inc.
Latest:
Drug Coverage and Decision Making in Medicare Part D EnrolleesThis pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.
Latest:
Influenza Vaccine–Type Differentiation Updates for 2020Seasonal influenza is usually active from October to May and is caused by A and B strains of the influenza virus.
Latest:
Exposing Benefits and Barriers: mHealth Use in Managing HemophiliaDespite medical recommendations, many patients do not consistently remain adherent to their prophylactic schedule.
Latest:
Pharmacists Address Proper Dosing of Anticoagulants in CAD and PADIn a Pharmacy Times® Insights series, 2 experts agree that communication is incredibly valuable when discussing guidelines and recommendations.
Latest:
Pre-Chemo Enzalutamide Approved for Metastatic Castration-Resistant Prostate CancerThe FDA has expanded the approval for enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive metastatic castration-resistant prostate cancer.
Latest:
Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes PatientsChanges in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
Latest:
Health-Systems Pharmacists: Part of a Multidisciplinary TeamWorking as a health systems pharmacist is a well-rounded career and offers job fulfillment, satisfaction, and great earning potential.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
Caterpillar Breaks New Ground Managing the Prescription Drug Supply ChainBy eliminating waste in the prescription drug supply chain, Caterpillar lowered total drug costs while copayment tiers remained unchanged.
Latest:
Perserverance After Match Day Uncertainty Leads to OpportunityMatch day can be one of the most uplifting, validating, and encouraging of days.
Latest:
NASP 2019: A Doctor's Perspective on Specialty PharmacyThe annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.
Latest:
Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic ArthritisAll primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.
Latest:
ADA's New CEO Takes Over in Time for 78th Scientific SessionsTracey D. Brown will welcome 16,000 attendees to the premier diabetes health care conference in her first month as chief executive of the American Diabetes Association.
Latest:
Opportunistic Infections: Better Have a Pharmacist OnboardApproximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Lasmiditan For the Acute Treatment of Migraine: An Opportunity For PharmacistsDespite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.
Latest:
Sav-Mor Pharmacy: Marketing From the Inside OutThe Illinois pharmacy chain has attained success as a result of good planning and successful marketing strategies.
Latest:
Association Between Sustained Glycated Hemoglobin Control and Healthcare CostsTotal cost of care for patients whose glycated hemoglobin levels were
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
